Abstract
Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.
Original language | English (US) |
---|---|
Pages (from-to) | 288-294 |
Number of pages | 7 |
Journal | Neurology: Clinical Practice |
Volume | 3 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2013 |
ASJC Scopus subject areas
- Clinical Neurology